Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Colorectal Neoplasms 38Stomach Neoplasms 24Rectal Neoplasms 19Pancreatic Neoplasms 17Lymphoma, Large B-Cell, Diffuse 14Colonic Neoplasms 14Esophageal Neoplasms 12Adenocarcinoma Of Esophagus 12Carcinoma, Non-Small-Cell Lung 10Neoplasms 9Neoplasm Metastasis 9Adenocarcinoma 9Cholangiocarcinoma 8Biliary Tract Neoplasms 6Ovarian Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Hepatocellular 4Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Carcinoma 3Bile Duct Neoplasms 3Advanced Solid Tumors 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2Recurrence 2

Interventions

Biopsy 9Specimen Handling 8Magnetic Resonance Spectroscopy 6duvelisib 5Cyclophosphamide 5ruxolitinib 4Vincristine 410-propargyl-10-deazaaminopterin 4pembrolizumab 3X-Rays 3Prednisone 3Etoposide 3Doxorubicin 3tazemetostat 2sodium-iodide symporter 2cemiplimab 2belinostat 2Photons 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immunoglobulin G 2Disulfides 2Cytarabine 2Bortezomib 2Azacitidine 2venetoclax 1talimogene laherparepvec 1romidepsin 1prednylidene 1pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, T-Cell × Oxaliplatin × 90 days × Clear all
NCT04984837 2026-06-04

Study of Lacutamab in Peripheral T-cell Lymphoma

The Lymphoma Academic Research Organisation

Phase 2 Active not recruiting
49 enrolled
Lymphoid

Recurrence, Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡